BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guan J, Chen XP, Zhu H, Luo SF, Cao B, Ding L. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. World J Gastroenterol 2004; 10(23): 3522-3527 [PMID: 15526378 DOI: 10.3748/wjg.v10.i23.3522]
URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3522.htm
Number Citing Articles
Noha M Hazem, Wagdi F ElKashef, Ibrahim M El-Sherbiny, Ahmed A Emam, Dalia Shaalan, Mohamed Sobh. Anticarcinogenic Effects of Capsaicin-Loaded Nanoparticles on In vitro Hepatocellular CarcinomaCurrent Chemical Biology 2021; 15(2): 188 doi: 10.2174/2212796814999201116211648
Reddy P. Nishanth, B.S. Ramakrishna, Radhika G. Jyotsna, Karnati R. Roy, Gorla V. Reddy, Pratap K. Reddy, Pallu Reddanna. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell lineEuropean Journal of Pharmacology 2010; 649(1-3): 74 doi: 10.1016/j.ejphar.2010.09.011
Upal Roy, Paul Barber, Yuk-Ching Tse-Dinh, Elena V. Batrakova, Debasis Mondal, Madhavan Nair. Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infectionsFrontiers in Microbiology 2015; 6 doi: 10.3389/fmicb.2015.00948
Alfred S.L. Cheng, Nathalie Wong, Ada M.Y. Tse, Kathy Y.Y. Chan, Kai K. Chan, Joseph J.Y. Sung, Henry L.Y. Chan. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinomaCancer Letters 2007; 253(1): 43 doi: 10.1016/j.canlet.2007.01.004
WEN-JING LIAN, GENG LIU, YUAN-JIE LIU, ZHI-WEI ZHAO, TAO YI, HONG-YING ZHOU. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancerOncology Reports 2013; 30(1): 193 doi: 10.3892/or.2013.2462
Shaymaa M. M. Yahya, Shadia A. Fathy, Zakaria A. El-Khayat, Safinaz E. El-Toukhy, Ahmed R. Hamed, Marwa G. A. Hegazy, Heba K. Nabih. Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular CarcinomaIndian Journal of Clinical Biochemistry 2018; 33(1): 21 doi: 10.1007/s12291-017-0651-8
Katrin Hoffmann, Zhi Xiao, Clemens Franz, Elvira Mohr, Susanne Serba, Markus W Büchler, Peter Schemmer. Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitroCancer Cell International 2011; 11(1) doi: 10.1186/1475-2867-11-40
Anna Poli, Antonio Di Pietro, Dusan Zigon, Helena Lenasi. Possible involvement of G-proteins and cAMP in the induction of progesterone hydroxylating enzyme system in the vascular wilt fungus Fusarium oxysporumThe Journal of Steroid Biochemistry and Molecular Biology 2009; 113(3-5): 241 doi: 10.1016/j.jsbmb.2009.01.006
SIYUAN CHEN, YALI WANG, WENWEN RUAN, XIAOMIN WANG, CHAO PAN. Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activityOncology Letters 2014; 8(5): 2333 doi: 10.3892/ol.2014.2521
Yiting Wang, Jing Cai, Xiaoli Zeng, Yajie Chen, Wei Yan, Yuming Ouyang, Dan Xiao, Zhiming Zeng, Long Huang, Anwen Liu. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signalingBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1866-9
Jin Liu, Mingyi Zhu, Yun Feng, Qianli Tang, Meng Xu. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinomaBioscience Reports 2020; 40(5) doi: 10.1042/BSR20190239
Alex Y. Strongin. Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2010; 1803(1): 133 doi: 10.1016/j.bbamcr.2009.04.009
Zhi Xiao, Nianhua Ding, Guiqing Xiao, Shouman Wang, Yuhui Wu, Lili Tang. Reversal of Multidrug Resistance by Gefitinib Via RAF1/ERK Pathway in Pancreatic Cancer Cell LineThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2012; 295(12): 2122 doi: 10.1002/ar.22552
Reddy P. Nishanth, Tammineni Prasad, Radhika G. Jyotsna, Pratap K. Reddy, Pallu Reddanna. Hepatoprotective Effects ofTerminalia chebulaFruit Extract against 2-AAF–Induced Hepatic Damage in Albino Mice: Role of MDR1 and COX-2Journal of Herbs, Spices & Medicinal Plants 2014; 20(4): 402 doi: 10.1080/10496475.2014.882283
Rong Hu, Guoxiang Shen, Usha Rao Yerramilli, Wen Lin, Changjiang Xu, Sujit Nair, Ah-Ng Tony Kong. In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the miceArchives of Pharmacal Research 2006; 29(10): 911 doi: 10.1007/BF02973914
Ning Han, Qingbo Zhang, Xiaoqiong Tang, Lang Bai, Libo Yan, Hong Tang. Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma CellsViruses 2023; 15(5): 1182 doi: 10.3390/v15051182
Cheol-Hee Choi, Hyun Bark, Jae Myung Chung, Eui Kyun Park, Sang-Hyun Kim. Elevated Reactive Oxygen Species but not Glutathione Regulate Mercury Resistance to AML-2/DX100 CellsImmunopharmacology and Immunotoxicology 2006; 28(3): 545 doi: 10.1080/08923970600927918
Denglin Chen, Derong Xie, Shuangshuang Guo, Qiong Yang, Zhimin Jiang, Zhuofei Bi, Wen Ma. ERK signaling pathway may induce gemcitabine chemoresistance in pancreatic cancer cell line SW1990 by regulating the expression of mdr-1 and RRM1 geneThe Chinese-German Journal of Clinical Oncology 2009; 8(1): 37 doi: 10.1007/s10330-008-0145-5
Aissam El-Aliani, Yassine El Mallali, Mohammed El Mzibri, Moulay Mustapha Ennaji. Emerging and Reemerging Viral Pathogens2020; : 11 doi: 10.1016/B978-0-12-814966-9.00002-0
Andrew C. Eppstein, John A. Sandoval, Patrick J. Klein, Heather A. Woodruff, Jay L. Grosfeld, Robert J. Hickey, Linda H. Malkas, C. Max Schmidt. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126Journal of Pediatric Surgery 2006; 41(1): 252 doi: 10.1016/j.jpedsurg.2005.10.047
Yong Tang, Fenghua Liu, Chunning Zheng, Shaochuan Sun, Yingsheng Jiang. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivationJournal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-73
Jiao Chen, Libing Lu, Yun feng, Hui Wang, Lila Dai, Yan li, Ping Zhang. PKD2 mediates multi-drug resistance in breast cancer cells through modulation of P-glycoprotein expressionCancer Letters 2011; 300(1): 48 doi: 10.1016/j.canlet.2010.09.005
Thomas Yau, Pierre Chan, Richard Epstein, Ronnie T Poon. Evolution of systemic therapy of advanced hepatocellular carcinomaWorld Journal of Gastroenterology 2008; 14(42): 6437-6441 doi: 10.3748/wjg.14.6437
Kentaro Hayashi, Hong Pu, Ibolya E Andras, Sung Yong Eum, Atsushi Yamauchi, Bernhard Hennig, Michal Toborek. HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood–Brain BarrierJournal of Cerebral Blood Flow & Metabolism 2006; 26(8): 1052 doi: 10.1038/sj.jcbfm.9600254
Mark A Feitelson, Helena MGPV Reis, Jingbo Pan, Marcy Clayton, Bill Sun, N Lale Satiroglu-Tufan, Zhaorui Lian. HBV X protein: elucidating a role in oncogenesisFuture Virology 2008; 3(5): 455 doi: 10.2217/17460794.3.5.455
Yaqiong Chen, Zhi Zhao, Yu Chen, Zhonglin Lv, Xin Ding, Renxi Wang, He Xiao, Chunmei Hou, Beifen Shen, Jiannan Feng, Renfeng Guo, Yan Li, Hui Peng, Gencheng Han, Guojiang Chen. An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancerScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08047-1
P.S. Sushma, Ganji Purnachandra Nagaraju. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy2019; : 45 doi: 10.1016/B978-0-12-817661-0.00004-4